Skip to search formSkip to main contentSkip to account menu

B-Cell Lymphomas

Known as: lymphoma b-cell, cell b lymphoma, b cell lymphomas 
A type of cancer that forms in B cells (a type of immune system cell). B-cell lymphomas usually occur in adults and may be either indolent (slow… 
National Institutes of Health

Related topics

Related topics

37 relations
50 ML rituximab 10 MG/ML InjectionAtypical lymphocyteB-LymphocytesBMI1 gene

Narrower (1)

Burkitt Lymphoma

Broader (1)

Lymphoma, Non-Hodgkin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from…
Diffuse large B-cell lymphoma (DLBCL) is stratified into prognostically favorable germinal center B-cell (GCB)-like and… 
Highly Cited
2011
Highly Cited
2011
Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.
PURPOSE Patients with diffuse large B-cell lymphoma (DLBCL) can be divided into prognostic groups based on the cell of origin of… 
Highly Cited
2011
Highly Cited
2011
An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma.
BACKGROUND Lenalidomide is an immunomodulatory agent with antitumor activity in B-cell malignancies. This phase II trial aimed to… 
Review
2010
Review
2010
B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma
B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements, also known as “double-hit” lymphomas (DHL), are rare neoplasms… 
Highly Cited
2009
Highly Cited
2009
Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas.
The miR-17 approximately 92 cluster is frequently amplified or overexpressed in human cancers and has emerged as the prototypical… 
Highly Cited
2005
Highly Cited
2005
Accumulation of miR-155 and BIC RNA in human B cell lymphomas.
We show that the microRNA miR-155 can be processed from sequences present in BIC RNA, a spliced and polyadenylated but non… 
Highly Cited
2005
Highly Cited
2005
BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas
In a previous study we demonstrated high expression of the non‐coding BIC gene in the vast majority of Hodgkin's lymphomas (HLs… 
Highly Cited
2004
Highly Cited
2004
Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas.
BACKGROUND The growth of most tumors depends on the formation of new blood vessels. In contrast to genetically unstable tumor… 
Highly Cited
2003
Highly Cited
2003
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
Mediastinal large B-cell lymphoma (MLBCL) is a recently identified subtype of diffuse large B-cell lymphoma (DLBCL) that… 
Review
2003
Review
2003
B cells under influence: transformation of B cells by Epstein–Barr virus
Epstein–Barr virus (EBV) is an extremely successful virus, infecting more than 90% of the human population worldwide. After… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)